Plus Therapeutics, Inc. · NASDAQ:PSTV
Sims Andrew John Hugh MacIntyre exercised options for 67,452 Plus Therapeutics, Inc. shares (Form 4)
Traded Apr 1, 2026 · Filed Apr 1, 2026
On Apr 1, 2026, Sims Andrew John Hugh MacIntyre (Chief Financial Officer) exercised options for 67,452 Plus Therapeutics, Inc. shares, leaving 173,913 shares. Filed Apr 1, 2026 (Form 4).
- Options exercised
- 67,452 shares
- Holding after
- 173,913 shares
- Trading plan
- No
- Role
- Chief Financial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Apr 1, 2026 | Common Stock | Option exercise | 38,323 | 144,784 | Direct | |
| Apr 1, 2026 | Common Stock | Option exercise | 29,129 | 173,913 | Direct |
Source
Related
- Plus Therapeutics, Inc.
- Sims Andrew John Hugh MacIntyre
- Plus Therapeutics, Inc. shareholders
- Form 4 · Sims Andrew John Hugh MacIntyre · Jul 1, 2026
- Form 4 · Andrews Ronald Asbury · Jul 1, 2026
- Form 4 · Hawkins Richard J · Jul 1, 2026
- Form 4 · Guse Kyle · Jul 1, 2026
- Form 4 · van Es-Johansson An · Jul 1, 2026
- Form 4 · Hedrick Marc H · Jul 1, 2026